Tactile Systems Technology (TCMD) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.20% |
| Dec 31, 2025 | 133.39% |
| Sep 30, 2025 | 155.18% |
| Jun 30, 2025 | 208.17% |
| Mar 31, 2025 | -130.47% |
| Dec 31, 2024 | 89.37% |
| Sep 30, 2024 | 20.61% |
| Jun 30, 2024 | 293.48% |
| Mar 31, 2024 | -126.91% |
| Dec 31, 2023 | -63.16% |
| Sep 30, 2023 | 27,956.25% |
| Jun 30, 2023 | 95.76% |
| Mar 31, 2023 | -140.81% |
| Dec 31, 2022 | 302.76% |
| Sep 30, 2022 | 50.88% |
| Jun 30, 2022 | 70.20% |
| Mar 31, 2022 | -107.71% |
| Dec 31, 2021 | -123.40% |
| Sep 30, 2021 | -357.09% |
| Jun 30, 2021 | 157.59% |
| Mar 31, 2021 | -118.71% |
| Dec 31, 2020 | 399.71% |
| Sep 30, 2020 | 117.50% |
| Jun 30, 2020 | -959.68% |
| Mar 31, 2020 | -130.52% |
| Dec 31, 2019 | 76.18% |
| Sep 30, 2019 | -12.71% |
| Jun 30, 2019 | 89.20% |
| Mar 31, 2019 | -37.49% |
| Dec 31, 2018 | 34.88% |
| Sep 30, 2018 | -32.12% |
| Jun 30, 2018 | 5,244.00% |
| Mar 31, 2018 | -102.24% |
| Dec 31, 2017 | 66.17% |
| Sep 30, 2017 | -64.56% |
| Jun 30, 2017 | 351.80% |
| Mar 31, 2017 | -163.22% |
| Dec 31, 2016 | 1,307.69% |
| Sep 30, 2016 | -17.16% |
| Jun 30, 2016 | 113.65% |
| Mar 31, 2016 | -616.96% |
| Dec 31, 2015 | 100.69% |
| Sep 30, 2015 | 143.90% |